2-甲基-2-丙基-4-(6 - {[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氢吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸

2-甲基-2-丙基-4-(6 - {[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氢吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸性质、用途与生产工艺

用途

2-甲基-2-丙基-4-(6 - {[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氢吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸 上下游产品信息

上游原料

下游产品

2-甲基-2-丙基-4-(6 - {[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氢吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸 生产厂家

866084-31-3, 2-甲基-2-丙基-4-(6 - {[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氢吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸 相关搜索:

• Anticancer
• 原料药
• 化学试剂
• 医用中间体
• 杂质对照品
• 对照品-杂质对照品
• 帕博西尼中间体
• C33H45N7O4
• 8660841-31-3
• 哌柏西利杂质Q
• 2-[[5-(4-BOC-1-哌嗪基)-2-吡啶基]氨基]-8-环戊基-5-甲基-6-(1-丙氧基乙烯基)吡啶并[2,3-D]嘧啶-7(8H)-酮
• 叔丁基4-(6-(8-环戊基-5-甲基-7-氧基-6-(1-丙氧乙烯基)-7,8-二氢吡啶[2,3-D]吡啶咪丁-2-基氨基)吡啶-3-基)哌嗪-1-羧酸酯
• 帕博西尼布杂质19
• 帕布昔利布(帕博西尼)杂质73
• 帕布昔利布26
• 2-甲基-2-丙基-4-(6-{[8-环戊基-5-甲基-7-氧代-6-(1-丙氧乙烯基)-7,8-二氢吡啶并[2,3-D]喗啶-2-基]氨基}-3-吡啶基)-1-哌嗪甲酸
• 4-(6-((6-(1-丁氧基乙烯基C-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-D]嘧啶-2-基C氨基)吡啶-3-基)哌嗪-1-甲酸叔丁酯(帕布昔利布中间体)
• 叔-丁基 4-(6-((6-(1-丁氧基乙烯基)-8-环戊基-5-甲基-7-氧亚基-7,8-二氢吡啶并[2,3-D]嘧啶-2-基)氨基)吡啶-3-基)哌嗪-1-甲酸基酯
• 4-{6-[(6-(1-丁氧基乙烯基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶[2,3-D]嘧啶-2-基胺基)吡啶-3-基)哌嗪-1-甲酸叔丁酯
• 帕博西尼杂质73
• 帕布昔利布标准品017
• 帕布西利布中间体2
• 2-甲基-2-丙基-4-(6-{[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二
• 4-{6-[6-(1-丁氧基-乙烯基)-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-D]嘧啶- 2-基氨基]-吡啶-3-基}-哌嗪-1-羧酸叔丁酯
• 帕布昔利布中间体二
• 帕布昔利布中间体2
• 4-(6-(8-环戊基-6-(1-正丁氧基乙烯基)-7,8-二氢-5-甲基-7-氧代吡啶并[2,3-D]嘧啶-2-基氨基)吡啶-3-基)哌嗪-1-羧酸叔丁酯
• 2-甲基-2-丙基-4-(6 - {[8-环戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氢吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸
• 4-(6-((6-(1-丁氧基乙烯基C-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-D]嘧啶-2-基C氨基)吡啶-3-基)哌嗪-1-甲酸叔丁酯
• 帕布西利布-中间体7
• 866084-31-3
• 2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-8-cyclopentyl-5-methyl-6-(1-propoxyvinyl)pyrido[2,3-d]pyrimidin-7(8H)-one
• tert-butyl 4-(6-(8-cyclopentyl-5-methyl-7-oxo-6(1-propoxyvinyl) -7,8-dihydropyrido[2,3-d]pyrimidin)-2-ylamino)pyridine-3-yl) piperazine-1-carboxylate
• tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvi...
• 1-Piperazinecarboxylic acid, 4-[6-[[6-(1-butoxyethenyl)-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]-3-pyridinyl]-, 1,1-dimethylethyl ester
• Palbociclib-017
• tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2
• Palbociclib impurity 19/Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
• Palbociclib Impurity 73
• 2-Methyl-2-propanyl 4-(6-{[8-cyclopentyl-5-methyl-7-oxo-6-(1-prop oxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino}-3-pyridin yl)-1-piperazinecarboxylate
• 4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester
• tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
• Palbociclib INT
• tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate